Partnership aims to generate $1 billion in biotech value through AI-powered drug discovery
Bahrain Mumtalakat Holding Company, the Kingdom’s sovereign wealth fund, has announced a landmark partnership with SandboxAQ, a global leader in AI and quantum technologies, to accelerate the development of a cutting-edge biotech ecosystem in Bahrain.
Under the agreement, Bahrain will license SandboxAQ’s advanced software and quantitative AI capabilities to identify therapeutic targets and develop novel drugs. The initiative is expected to generate over $1 billion in biotech assets, positioning Bahrain as a regional hub for innovation in life sciences.
“By combining our national resources with SandboxAQ’s world-class expertise, we are laying the foundation for a new era of innovation and economic growth.”
— HE Shaikh Abdulla bin Khalifa Al Khalifa, CEO, Mumtalakat
“This collaboration will harness the power of AI to accelerate drug discovery and attract more investment to the Kingdom,” said Jack Hidary, CEO of SandboxAQ.
The partnership will be guided by a joint research committee overseeing a three-year program focused on drug development. SandboxAQ’s Large Quantitative Models (LQMs), developed in partnership with NVIDIA, will play a central role in generating intellectual property and scientific breakthroughs.
“This is not just about technology—it’s about building a sustainable innovation economy,” Hidary added.
Aligned with Bahrain’s national strategy, the partnership reflects Mumtalakat’s commitment to long-term growth and portfolio diversification, ushering in a transformative chapter for the Kingdom’s health and biotech sectors.
